These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36156022)

  • 1. [Expert Panel Issues in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):991-993. PubMed ID: 36156022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Panel Discussion - Problems in the Cancer Genomic Medicine].
    Ishioka C; Muto M; Yachida S; Shirota H; Hirasawa A; Miyagawa K; Ashizawa K; Kinoshita I; Nishihara H; Matsuura N; Sakurai A
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1014-1017. PubMed ID: 36156030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interinstitutional Collaboration for Molecular Tumor Boards].
    Komine K; Shirota H
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):626-629. PubMed ID: 31164497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Sunami K
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Challenges in Expert Panel].
    Yachida S
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):994-996. PubMed ID: 36156023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer genomic medicine in Japan and the roles of pharmacists.
    Aomori T; Sakurai H; Nishihara H
    Pharmacogenet Genomics; 2022 Aug; 32(6):242-245. PubMed ID: 35696282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan.
    Kage H; Oda K; Muto M; Tsuchihara K; Okita N; Okuma Y; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Sakai D; Hirasawa A; Kubo M; Kenmotsu H; Akiyama N; Shinozaki-Ushiku A; Tanabe M; Ushiku T; Miyagawa K; Seto Y
    Cancer Sci; 2023 Jul; 114(7):3041-3049. PubMed ID: 37165760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Cancer Genomic Medicine in Kyushu Region and the Roles of Kyushu University Hospital as a Core Hospital for Cancer Genomic Medicine].
    Ito M; Baba E
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):873-877. PubMed ID: 34267019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multidisciplinary Collaboration and Education Program Required for Equalization of Cancer Genomic Medicine].
    Miyagawa K
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1002-1004. PubMed ID: 36156026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Issues of Equalization of Cancer Genomic Medicine-Focusing on the Current Status in Nagasaki Prefecture].
    Ashizawa K; Udo E; Soda M; Furusato B
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1005-1007. PubMed ID: 36156027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Nishida T
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1223-1227. PubMed ID: 30237359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
    Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of the Cancer Genomic Medicine in the Tohoku District-Activity of Tohoku University Hospital as the Cancer Genome Medicine Core Base Hospital in Japan].
    Ishioka C
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):878-881. PubMed ID: 34267020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
    Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H
    Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Role of Core Hospital of Cancer Genomic Medicine and Regional Cooperation].
    Shirota H; Komine K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1149-1152. PubMed ID: 32829345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Precision Medicine Provided by National Health Insurance].
    Muto M; Kondo T; Matsubara J; Kanai M; Matsumoto S; Ashida K; Suga J; Mukai K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1158-1163. PubMed ID: 32829347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infrastructure Required for Implementing Genomic Medicine and Expert Panel].
    Kanai M
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):622-625. PubMed ID: 31164496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and implementation of Cancer Genomic Medicine in Japan.
    Mukai Y; Ueno H
    Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Role of C-CAT, the Repository Database of Cancer Genomic Medicine in Japan].
    Yoshida T
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):630-634. PubMed ID: 31164498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.